Rates of heart disease, cancer, diabetes, and other noncommunicable diseases (NCDs) in low- and middle-income countries are increasing faster, in younger people, and with worse outcomes than in wealthier countries. In 2013 alone, NCDs killed eight million people before their sixtieth birthdays in developing countries. A new CFR-sponsored Independent Task Force report and accompanying interactive look at the factors behind this epidemic and the ways the United States can best fight it.

At present, human society is facing a health care crisis that is affecting patients worldwide. In the United States, it is generally believed that the major problem is lack of affordable access to health care (i.e. health insurance). This book takes an unprecedented approach to address this issue by proposing that the major problem is not lack of affordable access to health care per se, but lack of access to better, safer, and more affordable medicines. The latter problem is present not only in the United States and the developing world but also in countries with socialized health care systems, such as Europe and the rest of the industrialized world. This book provides a comparative analysis of the health care systems throughout the world and also examines the biotechnology and pharmaceutical industries. - Examines the health care structure of the United States, Europe, and the third world, both separately and comparatively - Offers primary source insight through in-depth interviews with pharmaceutical and health care industry leaders from around the world - Carefully explains, in clear terms, the intricacies of the health care and pharmaceutical system and how these intricacies have led to the current crisis - Offers concrete, comprehensive solutions to the health care crisis

While much progress has been made on achieving the Millenium Development Goals over the last decade, the number and complexity of global health challenges has persisted. Growing forces for globalization have increased the interconnectedness of the world and our interdependency on other countries, economies, and cultures. Monumental growth in international travel and trade have brought improved access to goods and services for many, but also carry ongoing and ever-present threats of zoonotic spillover and infectious disease outbreaks that threaten all. Global Health and the Future Role of the United States identifies global health priorities in light of current and emerging world threats. This report assesses the current global health landscape and how challenges, actions, and players have evolved over the last decade across a wide range of issues, and provides recommendations on how to increase responsiveness, coordination, and efficiency â€" both within the U.S. government and across the global health field.

"This book will serve as a comprehensive resource to study the different dimensions of the pandemic from multi-stakeholder's perspectives, analyzing the forces that determine how and to which extent that stakeholders contribute during a Pandemic, what are the successful models and where are the chances of improvement"--

Proposing a new view of global justice based on natural law, this book presents a discussion of the key ethical values in contemporary medicine and health, notably in relation to neglected diseases like malaria, Ebola and Zika. The lack of treatments for such diseases points to a global health crisis. Thana Cristina de Campos provides a general framework, based on global commutative justice, for discussion of the ethical responsibilities of international stakeholders, mapping the varying duties they have, and their content and force. She also addresses the urgent need for reforms to the international legal rules on bioethics, notably the system of intellectual property rights. These ideas will be of interest to those who are looking for a more nuanced view of the human right to health than that provided by advocates in the globalist mainstream.

In 2015, building on the advances of the Millennium Development Goals, the United Nations adopted Sustainable Development Goals that include an explicit commitment to achieve universal health coverage by 2030. However, enormous gaps remain between what is achievable in human health and where global health stands today, and progress has been both incomplete and unevenly distributed. In order to meet this goal, a deliberate and comprehensive effort is needed to improve the quality of health care services globally. Crossing the Global Quality Chasm: Improving Health Care Worldwide focuses on one particular shortfall in health care affecting global populations: defects in the quality of care. This study reviews the available evidence on the quality of care worldwide and makes recommendations to improve health care quality globally while expanding access to preventive and therapeutic services, with a focus in low-resource areas. Crossing the Global Quality Chasm emphasizes the organization and delivery of safe and effective care at the patient/provider interface. This study explores issues of access to services and commodities, effectiveness, safety, efficiency, and equity. Focusing on front line service delivery that can directly impact health outcomes for individuals and populations, this book will be an essential guide for key stakeholders, governments, donors, health systems, and others involved in health care.

Recent epidemics have prompted large-scale international interventions, aimed at mitigating the spread of disease in a globalized world. During a crisis, however, global health actions – including planning and organizing, communicating about risk, and cost–benefit evaluations – aren’t usually part of a single, integrated global response. Arguing that an uncoordinated approach can be challenged by local conditions and expectations, generating a wide range of resistance and difficulties, this volume provides important insights for future outbreak management and global health governance. Drawing on experiences with A(H1N1) and Ebola virus disease, the book is divided into three parts looking at how responses to global health crises have developed, lessons learned from particular pandemics and the ethical implications of our management of them. Individual chapters focus on, among other issues, financing, cost–benefit analysis, matrix management, risk communication and organizational strategies. Taking a social science perspective, this valuable book outlines the current state of global health emergency responses and explores ways in which they can be improved. It is a useful read for academics and practitioners interested in global health, the sociology of health and illness, health economics and emergency management.